Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 4
2013 4
2014 3
2015 5
2016 9
2017 3
2018 7
2019 4
2020 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Tuberculosis-Related Malnutrition: Public Health Implications.
Ter Beek L, Alffenaar JC, Bolhuis MS, van der Werf TS, Akkerman OW. Ter Beek L, et al. Among authors: bolhuis ms. J Infect Dis. 2019 Jun 19;220(2):340-341. doi: 10.1093/infdis/jiz091. J Infect Dis. 2019. PMID: 30835281 No abstract available.
Reduced moxifloxacin exposure in patients with tuberculosis and diabetes.
Dekkers BGJ, Bolhuis MS, Ter Beek L, de Lange WCM, van der Werf TS, Alffenaar JC, Akkerman OW. Dekkers BGJ, et al. Among authors: bolhuis ms. Eur Respir J. 2019 Sep 5;54(3):1900373. doi: 10.1183/13993003.00373-2019. Print 2019 Sep. Eur Respir J. 2019. PMID: 31048350 Free article. No abstract available.
Emerging drugs and alternative possibilities in the treatment of tuberculosis.
Hofman S, Segers MM, Ghimire S, Bolhuis MS, Sturkenboom MG, Van Soolingen D, Alffenaar JW. Hofman S, et al. Among authors: bolhuis ms. Expert Opin Emerg Drugs. 2016;21(1):103-16. doi: 10.1517/14728214.2016.1151000. Epub 2016 Feb 20. Expert Opin Emerg Drugs. 2016. PMID: 26848966 Review.
Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid.
van den Elsen SHJ, Akkerman OW, Wessels M, Jongedijk EM, Ghimire S, van der Werf TS, Bolhuis MS, Touw DJ, Alffenaar JC. van den Elsen SHJ, et al. Among authors: bolhuis ms. Eur Respir J. 2020 Oct 22;56(4):2000803. doi: 10.1183/13993003.00803-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32398308 No abstract available.
End TB with precision treatment!
van der Burgt EP, Sturkenboom MG, Bolhuis MS, Akkerman OW, Kosterink JG, de Lange WC, Cobelens FG, van der Werf TS, Alffenaar JW. van der Burgt EP, et al. Among authors: bolhuis ms. Eur Respir J. 2016 Feb;47(2):680-2. doi: 10.1183/13993003.01285-2015. Eur Respir J. 2016. PMID: 26828056 Free article. No abstract available.
Pharmacokinetics of 2,000 Milligram Ertapenem in Tuberculosis Patients.
Zuur MA, Ghimire S, Bolhuis MS, Wessels AMA, van Altena R, de Lange WCM, Kosterink JGW, Touw DJ, van der Werf TS, Akkerman OW, Alffenaar JWC. Zuur MA, et al. Among authors: bolhuis ms. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02250-17. doi: 10.1128/AAC.02250-17. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29439978 Free PMC article.
42 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page